455 — Tianda Pharmaceuticals Share News
0.000.00%
- HK$191.35m
- HK$291.33m
- HK$322.95m
Brief: Tianda Pharmaceuticals Clarifies On Fraudulent Fund Raising Scams
Brief: Tianda Pharmaceuticals Sees Loss Attributable For Interim Period Increase To Not Less Than HK$27 Mln
Brief: Tianda Pharmaceuticals Says Unit Granted Drug Registration Approval Of Ibuprofen Suspension By NMPA
Brief: Tianda Pharmaceuticals Says Drug Registration Approval Of "Nicorandil For Injection" By NMPA
Brief: Tianda Pharmaceuticals Sees Increase In Both Revenue And Gross Profit For Year
Brief: Tianda Pharmaceuticals Sees Increase In Revenue And Gross Profit By Over 20% For Six Months
Brief: Tianda Pharmaceuticals Says Unit To Buy 45% Stake In Yunnan Meng Sheng Pharmaceutical
Brief: Tianda Pharmaceuticals Says Co Decided To Increase Zhuhai Base's Production Capacity
Brief: Tianda Pharmaceuticals Says From 19 Oct-24 Oct, Chairman Bought 1.9 Mln Shares On Market
Brief: Tianda Pharmaceuticals Says Research And Development And Production Base In Biomedicine Industrial Park Has Been Put Into Production
Brief: Tianda Pharmaceuticals Enters Into Agreement With Zhong Ji Longevity Science Group
Brief: Tianda Pharmaceuticals Sees FY Loss Attributable Of Hk$27 Million
Brief: Tianda Pharmaceuticals Says Unit Enters Technology Transfer Contract
Brief: Tianda Pharmaceuticals Says Unit To Terminate Agreement For Acquisition Of Interests
Brief: Tianda Pharmaceuticals Says Unit To Acquire 50.1% Of Issued Shares Of Yeung & Young Medicare Centre
Brief: Tianda Pharma Says Anti-Epidemic Granules Approved By Australian Register Of Therapeutic Goods
Brief: Tianda Pharmaceuticals Sees Decline In Profit Attributable For FY
Brief: Tianda Pharmaceuticals Says Unit Signed Contract With Guangdong Jinhuihua Group
Brief: Tianda Pharmaceuticals Announces Disposal Of Interest In A Unit